Company registration number 14791823 (England and Wales)
MEDGATE PRIME LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2025
PAGES FOR FILING WITH REGISTRAR
MEDGATE PRIME LTD
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2
MEDGATE PRIME LTD
BALANCE SHEET
AS AT
30 APRIL 2025
30 April 2025
- 1 -
2025
2024
Notes
£
£
£
£
Current assets
-
-
Creditors: amounts falling due within one year
3
(14,772)
(14,772)
Net current liabilities
(14,772)
(14,772)
Capital and reserves
Called up share capital
100
100
Profit and loss reserves
(14,872)
(14,872)
Total equity
(14,772)
(14,772)

For the financial year ended 30 April 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved and signed by the director and authorised for issue on 25 September 2025
Mr KD Oduro
Director
Company registration number 14791823 (England and Wales)
MEDGATE PRIME LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2025
- 2 -
1
Accounting policies
Company information

Medgate Prime Ltd is a private company limited by shares incorporated in England and Wales. The registered office is Elthorne Gate, 64 High Street, Pinner, England, HA5 5QA.

1.1
Reporting period

The prior year financial statements represented the Company’s first set of accounts following incorporation and covered a period of one year and 19 days. The current year financial statements have been prepared on a non-trading basis, as the Company did not undertake any trading activities during the year. Accordingly, the comparative figures, together with the related notes, may not be directly comparable with those of the current year.

1.2
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, [modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value]. The principal accounting policies adopted are set out below.

 

 

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
0
0
3
Creditors: amounts falling due within one year
2025
2024
£
£
Other creditors
14,217
14,217
Accruals and deferred income
555
555
14,772
14,772
2025-04-302024-05-01falsefalsefalse25 September 2025CCH SoftwareCCH Accounts Production 2025.200No description of principal activityMr KD Oduro147918232024-05-012025-04-30147918232025-04-30147918232024-04-3014791823core:ShareCapital2025-04-3014791823core:ShareCapital2024-04-3014791823core:RetainedEarningsAccumulatedLosses2025-04-3014791823core:RetainedEarningsAccumulatedLosses2024-04-3014791823bus:Director12024-05-012025-04-30147918232023-04-112024-04-3014791823core:CurrentFinancialInstruments2025-04-3014791823core:CurrentFinancialInstruments2024-04-3014791823bus:PrivateLimitedCompanyLtd2024-05-012025-04-3014791823bus:SmallCompaniesRegimeForAccounts2024-05-012025-04-3014791823bus:FRS1022024-05-012025-04-3014791823bus:AuditExemptWithAccountantsReport2024-05-012025-04-3014791823bus:FullAccounts2024-05-012025-04-30xbrli:purexbrli:sharesiso4217:GBP